CALR and cancer: The recently discovered function of calreticulin in cancer cells is preventing the p53-mediated caspase-independent cell-death response; the latter can be induced by calreticulin knockdown, leading to mitochondrial Ca2+ overload followed by cell killing through a mitochondrial permeability transition pore-dependent mechanism [280].